Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time

Autologous serum eye drops with added hyaluronic acid in the conjunctival sac: a study of the residual time - A study of autologous serum eye drops with added hyaluronic acid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002194

Enrollment

Registered

2009-07-21

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keratoconjunctival dysfunction,severe dry eye,late-onset bleb leak after trabeculectomy

Interventions

apply 10 microliter autologous serum eye drops added hyaluronic acid(autologous serum50%,hyaleinmini0.3%,33%, cravit16.7%),48hrs,apply 10 microliter autologous serum eye drops added saline(autologous

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: persons without severe keratoconjunctival dysfunction

Exclusion criteria

Exclusion criteria: paient with severe keratoconjunctival dysfunction

Design outcomes

Primary

Measure	Time frame
Albumin concentration in the conjunctival sac 10 min.,30min.,1hr and 3hrs.after administration of autologous serum eye drops added hyaluronic acid	—

Countries

Japan

Contacts

Public ContactHideto sagara

Marui Eye Clinic Director

hide1234@ruby.ocn.ne.jp0244-25-7488

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026